People with advanced cancers who reported their symptoms weekly using a digital tool received more timely, and potentially life-saving treatment, compared to those who were evaluated less frequently via regular in-person clinical visits, according to findings from a nationwide study. The PRO-TECT (Patient Reported Outcomes To Enhance Cancer Treatment) trial was led by researchers at the University of North Carolina Lineberger Comprehensive Cancer Center and conducted at community cancer centers.